[139 Pages Report] The global downstream processing market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021.

In this report, the global market is broadly segmented by technique, product, application, end user, and region. On the basis of product, the market is classified into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products. In 2016, the chromatography columns and resins segment accounted for the largest share of the market. The constant need for newer and different types of columns and resins is likely to fuel market growth

Based on technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the market. This high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market.

Based on application, the downstream processing market is categorized into monoclonal antibody (mAbs) production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. In 2016, the vaccine production segment accounted for the largest share of the market. Technological advancement in the downstream purification technology to develop high-quality products such as Vaccines at lower costs is expected to drive the growth of this segment.

Based on end user, the market is segmented into biopharmaceutical manufacturers and contract manufacturing organizations (CMOs). In 2016, the biopharmaceutical manufacturers segment accounted for the largest share of the market. The increasing demand for biopharmaceuticals among the aging population is expected to accelerate the growth of the biopharmaceutical manufacturers� end-user segment.

The growth of this market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry. Emerging markets such as Asia-Pacific provide new growth opportunities to players in the market. On the other hand, the high cost of instruments and the need for skilled professionals are expected to restrain the growth of this market to a certain extent during the forecast period. In addition, purification bottleneck, lack of single-use options, and dearth of skilled professionals are the major challenges in the downstream processing market

The market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).

Stakeholders

Vendors/service providers

Research and consulting firms

Biopharmaceutical manufacturers

Contract manufacturing organizations (CMOs)

Contract research organizations (CROs)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

The market study doesn�t cover the market size in terms of volume

Some companies in this market are privately owned and their revenues are not available in the public domain. Hence, revenue for those companies are not included in this report

Company developments not reported in the public domain are not included in this report

Particular Scope Region North America

U.S.

Canada

Europe

Asia-Pacific

RoW Historical Years 2014 Base Year 2015 Estimated Year 2016-e Forecast Period 2016-e�2021-p Revenue Currency USD

Market Segmentation

This research report categorizes the market on the basis of technique, product, application, end user, and region.

Global Downstream processing Market, by Technique

Purification

Solid-liquid Separation

Clarification/Concentration

Global Downstream processing Market, by Product

Chromatography Columns and Resins

Filters

Membrane Adsorbers

Single-use Products

Other Products (Consumables and Accessories)

Global Downstream processing Market, by Application

Monoclonal Antibody Production

Vaccine Production

Insulin Production

Immunoglobulin Production

Erythropoietin Production

Other Applications (Interferons, Fusion Proteins, Growth Hormones, Blood Coagulation Factors, Anticoagulants, Medical Enzymes, Anti-bacterial (Antibiotics), and Colony Stimulating Factors)

Global Downstream processing Market, by End User

Biopharmaceutical Manufacturers

Contract Manufacturing Organizations (CMOs)

Global Downstream processing Market, by Region

North America U.S. Canada

Europe

Asia-Pacific

Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Geographical Analysis

Further breakdown of the APAC downstream processing market into China, Japan, India, and Rest of Asia-Pacific

Further breakdown of the European market into Germany, France, the U.K., and Rest of Europe

Company Information

Detailed analysis and profiling of additional market players (Up to 5)

The global downstream processing market is projected to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021. In this report, the global market is broadly segmented on the basis of technique, product, application, end user, and region.

Major factors driving the growth of the market are increasing R&D expenditure in the biopharmaceutical industry and increasing demand for biopharmaceuticals. However, the need for skilled professionals and the high cost of instruments are expected to restrain the growth of this market. On the other hand, patent expiration of blockbuster biopharmaceutical products represents significant growth opportunities for the key players in the market.

On the basis of product, the market is broadly classified into chromatography columns and resins, membrane adsorbers, single-use products, filters, and other products (consumables and accessories). The chromatography columns and resins segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the constant need for newer and different types of columns and resins.

On the basis of technique, the downstream processing market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the market. This high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market.

The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Countries like China, Japan, India, and South Korea, are expected to drive the demand for downstream processing products in the coming years. Also, growth in these markets will be fueled by significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise and academic excellence.

North America is the world�s largest pharmaceutical market and a leader in biopharmaceutical research. North America (comprising the U.S. and Canada) accounted for the largest share of the global market in 2016. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region.

The Downstream Processing Market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst